Prospective observational study of stereotactic body radiation therapy for pancreatic cancer

Prospective observational study of stereotactic body radiation therapy for pancreatic cancer - Prospective observational study of stereotactic body radiation therapy for pancreatic cancer

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000045916

Enrollment

Registered

2021-10-29

Start date

2021-09-03

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

localized pancreatic cancer

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. ECOG performance status of 0-2 2. Patients with pathologically proven or clinically diagnosed pancreatic cancer 3. Stereotactic radiation therapy for pancreatic cancer is planned 4. Written informed consent

Exclusion criteria

Exclusion criteria: 1. History of previous radiation therapy or surgery for pancreatic cancer. 2. Patients who are pregnant or suspected to be pregnant. 3. Patients who are breastfeeding. 4. Patients with severe psychological disorder 5. Inappropriate for study participation by the lead principal investigator

Design outcomes

Primary

Measure	Time frame
1. Overall survival	—

Secondary

Measure	Time frame
2. Toxicity 3. Progression free survival 4. Local control 5. Quality of life 6. Actual status of radiation therapy	—

Countries

Japan

Contacts

Public ContactNorio Katoh

Hokkaido University Faculty of Medicine Department of Radiation Oncology

noriwokatoh@med.hokudai.ac.jp011-706-5977

Outcome results